About Chosen Diagnostics
Chosen Diagnostics is a company based in New Orleans (United States) founded in 2011. Chosen Diagnostics operates in a competitive market with competitors including Inscripta, GenScript, OncoDNA, Sino Biological and BioLife Solutions, among others.
- Headquarter New Orleans, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Chosen Diagnostics Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$224.76 K (USD), Grant
Jun 15, 2020
-
Investors
HHS
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Chosen Diagnostics
Investors in Chosen Diagnostics
Chosen Diagnostics has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, America’s Seed Fund and New Orleans BioInnovation Center.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund backed by the US Government
|
Locked | Locked | Locked | |
|
A center dedicated to supporting biotech innovators in Louisiana.
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Chosen Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Chosen Diagnostics
Investment portfolio details for Chosen Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Chosen Diagnostics
Detailed financials for Chosen Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Chosen Diagnostics Comparisons
Peer comparison for Chosen Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Chosen Diagnostics
Chosen Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inscripta, GenScript, OncoDNA, Sino Biological and BioLife Solutions, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Speech recognition solutions are provided by Inscripta for healthcare professionals.
|
|
| Locked | Locked | Locked |
Reagents and instruments are provided for life sciences research.
|
|
| Locked | Locked | Locked |
Genomic and theranostic services for oncology precision medicine are delivered.
|
|
| Locked | Locked | Locked |
Reagents and kits are provided for clinical research applications.
|
|
| Locked | Locked | Locked |
Tissue hypothermic storage and cryopreservation freeze media are developed.
|
|
| Locked | Locked | Locked |
Develops tools and products for research and clinical application
|
Detailed competitors of Chosen Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Chosen Diagnostics
Complete news archive for Chosen Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chosen Diagnostics
Chosen Diagnostics was founded in 2011 and raised its 1st funding round 7 years after it was founded.
Chosen Diagnostics is headquartered in New Orleans, United States. It is registered at New Orleans, Louisiana, United States.
Chosen Diagnostics was founded in 2011 in New Orleans, United States, within the molecular diagnostics sector. Neonatal DDx, a diagnostic kit for necrotizing enterocolitis in premature infants, has been developed by the company. Human trials involving 49 patients have been completed, achieving 93 percent accuracy in disease identification. Operations focus on advancing diagnostic tools for neonatal bowel disorders.
Chosen Diagnostics's top competitors include Sino Biological, OncoDNA and BioLife Solutions.
Chosen Diagnostics has 3 investors. Key investors include HHS, America’s Seed Fund, and New Orleans BioInnovation Center.